Gilead Sciences reports Q3 adjusted EPS $1.84, consensus $1.63

Reports Q3 revenue $5.596B, consensus $5.38B. Total product sales for the third quarter of 2018 were $5.5 billion compared to $6.4 billion for the same period in 2017. Product sales for the third quarter of 2018 were $4.1 billion in the United States, $873 million in Europe and $451 million in other locations. Product sales for the third quarter of 2017 were $4.5 billion in the United States, $1.2 billion in Europe and $663 million in other locations.
https://thefly.com/landingPageNews.php?id=2811163